Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Edinburgh vets treat cat with rare cancer
Misha in recovery.

Misha the cat is now in remission from plasma cell cancer. 

Misha the 14-year-old shorthair cat is in remission from plasma cell cancer after care from several teams at the Royal (Dick) School of Veterinary Studies.

The cancer was discovered when preparation for dental work revealed that there was a change in Misha's liver health, and from there, it was discovered that he had cancer affecting several of his organs.

After further testing, it was discovered that Misha had multicentric plasma cell neoplasia, which had caused tumours in his spleen, liver and on a lymph node. 

Collaborating on Misha's treatment, teams from feline medicine, surgery, intensive care, pathology, oncology, and dentistry were able to remove the cat's spleen and the tumours on his lymph node, and used chemotherapy to treat the tumours on his liver. 

Four months post-treatment, scans of Misha have suggested his condition to be significantly better. He has no visible lesions on his organs, and his enzyme levels have improved. Still recovering at home, Misha is receiving ongoing low-dose chemotherapy. 

Misha's owner, and radiologist at the Dick Vet, Tobias Schwarz, commented: “I’m very happy that Misha is now doing so well. His illness highlights the importance of regular health checks to help spot issues that may otherwise be undiagnosed, and the benefit of treating animals early on their illness, to improve their chances of recovery.

“With advances in oncology, successful treatment of cancer in animals is becoming more common, and consequently other important diseases, such as dental disorders, need to be considered for treatment as well, if we want to improve the health and welfare of our animals.”

 

Image (C) The Royal (Dick) School of Veterinary Studies

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.